Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Forbes, Catherine A ^a   Scalzo, Anthony A ^a   Degli Esposti, Mariapia A ^a,b   Coudert, Jerome D ^a,b  

^a LIONS EYE INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; LY49C RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; KLRA3 PROTEIN, MOUSE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SELECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOSKELETON; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE REPLICATION; KINETICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYMERASE CHAIN REACTION; POLYMERIZATION; PROTEIN INTERACTION; VIROGENESIS; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; MUROMEGALOVIRUS; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; CYTOMEGALOVIRUS INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A;

EID: 84901687568     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004161     Document Type: Article

References (52)

1. Biron CA, Byron KS, Sullivan JL, (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320: 1731-1735.
2. Eidenschenk C, Dunne J, Jouanguy E, Fourlinnie C, Gineau L, et al. (2006) A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet 78: 721-727.
3. Alford CA, Britt WJ (1996) Cytomegalovirus; Fields BN, editor. New York: Raven Press. 629-660 p.
4. Pyzik M, Kielczewska A, Vidal SM, (2008) NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Semin Immunol 20: 331-342.
5. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, (2008) Functions of natural killer cells. Nat Immunol 9: 503-510.
6. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, et al. (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
7. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, et al. (2001) Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194: 29-44.
8. Lee SH, Girard S, Macina D, Busa M, Zafer A, et al. (2001) Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28: 42-45.
9. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL, (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
10. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826-8831.
11. Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, et al. (2003) Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A 100: 13483-13488.
12. Booth TW, Scalzo AA, Carrello C, Lyons PA, Farrell HE, et al. (1993) Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch Virol 132: 209-220.
13. Corbett AJ, Coudert JD, Forbes CA, Scalzo AA, (2011) Functional Consequences of Natural Sequence Variation of Murine Cytomegalovirus m157 for Ly49 Receptor Specificity and NK Cell Activation. J Immunol 186: 1713-1722.
14. Berry R, Ng N, Saunders PM, Vivian JP, Lin J, et al. (2013) Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat Immunol 14: 699-705.
15. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
16. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, et al. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
17. Orr MT, Murphy WJ, Lanier LL, (2010) 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 11: 321-327.
18. Pignatelli S, Dal Monte P, Rossini G, Landini MP, (2004) Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 14: 383-410.
19. Scalzo AA, Brown MG, Chu DT, Heusel JW, Yokoyama WM, et al. (1999) Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics 49: 238-241.
20. Brennan J, Lemieux S, Freeman JD, Mager DL, Takei F, (1996) Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J Exp Med 184: 2085-2090.
21. Scarpellino L, Oeschger F, Guillaume P, Coudert JD, Levy F, et al. (2007) Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis. J Immunol 178: 1277-1284.
22. Doucey MA, Scarpellino L, Zimmer J, Guillaume P, Luescher IF, et al. (2004) Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol 5: 328-336.
23. Karre K, Ljunggren HG, Piontek G, Kiessling R, (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
24. Sun JC, Lanier LL, (2008) Cutting edge: viral infection breaks NK cell tolerance to "missing self". J Immunol 181: 7453-7457.
25. Bryceson YT, Long EO, (2008) Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 20: 344-352.
26. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA, (2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4: 175-181.
27. Fodil-Cornu N, Lee SH, Belanger S, Makrigiannis AP, Biron CA, et al. (2008) Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol 181: 6394-6405.
28. Hayakawa Y, Smyth MJ, (2006) CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity. J Immunol 176: 1517-1524.
29. Hengel H, Reusch U, Gutermann A, Ziegler H, Jonjic S, et al. (1999) Cytomegaloviral control of MHC class I function in the mouse. Immunol Rev 168: 167-176.
30. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, et al. (2010) Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J Exp Med 207: 2663-2673.
31. Pyzik M, Charbonneau B, Gendron-Pontbriand EM, Babic M, Krmpotic A, et al. (2011) Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. J Exp Med 208: 1105-1117.
32. van Dommelen SL, Tabarias HA, Smyth MJ, Degli-Esposti MA, (2003) Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J Virol 77: 1877-1884.
33. Held W, Mariuzza RA, (2008) Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol 8: 269-278.
34. Veillette A, Latour S, Davidson D, (2002) Negative regulation of immunoreceptor signaling. Annu Rev Immunol 20: 669-707.
35. Radosevic K, van Leeuwen MT, Segers-Nolten IM, Figdor CG, de Grooth BG, et al. (1994) Changes in actin organization during the cytotoxic process. Cytometry 15: 320-326.
36. Krzewski K, Chen X, Strominger JL, (2008) WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc Natl Acad Sci U S A 105: 2568-2573.
37. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR, (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171: 1469-1483.
38. Back J, Chalifour A, Scarpellino L, Held W, (2007) Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc Natl Acad Sci U S A 104: 3978-3983.
39. Chalifour A, Scarpellino L, Back J, Brodin P, Devevre E, et al. (2009) A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30: 337-347.
40. Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, et al. (2003) Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 23: 6291-6299.
41. Kleijnen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, et al. (1997) A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 16: 685-694.
42. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, et al. (1999) A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18: 1081-1091.
43. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, et al. (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57-66.
44. Li NL, Fu L, Uchtenhagen H, Achour A, Burshtyn DN, (2013) Cis association of leukocyte Ig-like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18. Eur J Immunol 43: 1042-1052.
45. Pircher H, Mak TW, Lang R, Ballhausen W, Ruedi E, et al. (1989) T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO J 8: 719-727.
46. Chalmer JE, Mackenzie JS, Stanley NF, (1977) Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37: 107-114.
47. Farrell HE, Shellam GR, (1989) Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice. J Gen Virol 70 (Pt 10):: 2573-2586.
48. Xu J, Lyons PA, Carter MD, Booth TW, Davis-Poynter NJ, et al. (1996) Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77 (Pt 1):: 49-59.
49. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG, (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33: e36.
50. Redwood AJ, Messerle M, Harvey NL, Hardy CM, Koszinowski UH, et al. (2005) Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol 79: 2998-3008.
51. Alter G, Malenfant JM, Altfeld M, (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22.
52. Brunner KT, Mauel J, Cerottini JC, Chapuis B, (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14: 181-196.